Statistics
PPV-MF, PET-MF
The study analysis used epidemiologic methods with primary use of descriptive statistical methods. All data were analyzed descriptively. In cases of confidence intervals or The analysis was performed on the full analysis set population, which included patients with informed consent; a diagnosis of PMF, PPV-MF, or PET-MF; and documented administration of RUX during the study. Pt cohorts were separated into JAKi-naïve patients (Arm A) and JAKi-pretreated patients (Arm B).Concomitant medications were analyzed using the Anatomical Therapeutic Chemical classification system (Level 1) preferred terms (Patients) according to the drug dictionary of the World Health Organization.AEs were coded using MedDRA version 23.1 and were analyzed using frequency tables, presenting the numbers and percentages of subjects having any AE, having an AE in each primary system organ class, and having each individual AE (PT).